One of the principal functions of OPCML as a tumor suppressor protein is to inactivate receptor tyrosine kinases (RTKs) by binding and chaperoning RTKs to the lipid raft followed by dephosphorylation of the activated RTK and subsequently driving endocytosis, leading to degradation of that RTK. The gene discussed is OPCML; the disease is neoplasm.